Successful treatment of invasive aspergillosis in two patients with acute myelogenous leukemia.
Invasive aspergillosis is a severe, devastating fungal infection that is seen in patients with hematologic malignancies and profound neutropenia. Despite aggressive treatment, the outcome is poor without neutrophil recovery. The authors describe two children with acute myelogenous leukemia (AML) with extensive invasive aspergillosis who were successfully treated both for their infection and the underlying malignancy. These patients were treated aggressively for their infections and simultaneously were able to complete treatment of their AML. Currently both patients are alive without evidence of fungal infection or AML. Patients with hematologic malignancies can survive severe, invasive aspergillosis during prolonged periods of neutropenia with a combination of antifungal and growth factor therapies, donor granulocyte infusions, and surgical debridement.
Singer
Melissa S
MS
Department of Pediatic Hematology/Oncology, Children's natonal Medical Center, Washington, DC 20010, USA.
Seibel
Nita L
NL
Vezina
Gilbert
G
Choi
Sukgi S
SS
Dinndorf
Patricia A
PA
D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use; D001228:Aspergillosis / Q000628:therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008297:Male
D016179:Granulocyte Colony-Stimulating Factor; D000666:Amphotericin B